| Nov 14 |
Oncolytics Biotech Inc. (ONCY) Q3 2024 Earnings Call Transcript
|
| Nov 13 |
Oncolytics Biotech Inc (ONCY) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
|
| Nov 12 |
Oncolytics Biotech GAAP EPS of -$0.12 misses by $0.04
|
| Nov 12 |
Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Oct 7 |
ONCY Stock Up on Regulatory Update From Breast Cancer Program
|
| Oct 7 |
Oncolytics targets accelerated approval for oncolytic virus therapy
|
| Oct 4 |
Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path
|
| Sep 19 |
Oncolytics Biotech Reports "Favorable" Results for BRACELET-1 Breast Cancer Study
|
| Sep 19 |
Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study
|
